In animal studies, chronic intermittent hypoxia (CIH) emulating the episodic desaturations of obstructive sleep apnea (OSA) is associated with either reduced or preserved somatic weight accrual and yet induces significant alterations in metabolism such as dyslipidemia and increased insulin resistance [1–4]. This evidence concerns the gene INS and obstructive sleep apnea syndrome.